Exact Mass: 634.4811

Exact Mass Matches: 634.4811

Found 98 metabolites which its exact mass value is equals to given mass value 634.4811, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0)

(2S)-3-hydroxy-2-(pentadecanoyloxy)propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C38H66O7 (634.4808)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808)


DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808)


DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808)


DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0)

(2S)-3-hydroxy-2-(pentadecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808)


DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808)


DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0)

(2S)-3-hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808)


DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808)


DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808)


DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0)

(2S)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808)


DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0)

(2S)-3-hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808)


DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0)

(2S)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808)


DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808)


DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0)

(2S)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

2-Isopentenyldehydrosaproxanthin

2-Isopentyl-1,2,3,4-Tetradehydro-1,2-dihydro-beta,psi-carotene-3,1-diol

C45H62O2 (634.475)


   

Phosphorotrithiousacid, tridodecyl ester

Phosphorotrithiousacid, tridodecyl ester

C36H75PS3 (634.4768)


   

Demethylmenaquinone-7

Demethylmenaquinone-7

C45H62O2 (634.475)


   

DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0)

C38H66O7 (634.4808)


   

DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C38H66O7 (634.4808)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0)

C38H66O7 (634.4808)


   

DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0)

C38H66O7 (634.4808)


   

DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C38H66O7 (634.4808)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0)

C38H66O7 (634.4808)


   

DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0)

C38H66O7 (634.4808)


   

DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C38H66O7 (634.4808)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0)

C38H66O7 (634.4808)


   

DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0)

C38H66O7 (634.4808)


   

DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C38H66O7 (634.4808)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0)

C38H66O7 (634.4808)


   

DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0)

C38H66O7 (634.4808)


   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C38H66O7 (634.4808)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0)

C38H66O7 (634.4808)


   

DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0)

C38H66O7 (634.4808)


   

DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C38H66O7 (634.4808)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0)

C38H66O7 (634.4808)


   

DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0)

C38H66O7 (634.4808)


   

DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C38H66O7 (634.4808)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0)

C38H66O7 (634.4808)


   

DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0)

C38H66O7 (634.4808)


   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C38H66O7 (634.4808)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0)

C38H66O7 (634.4808)


   

DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C38H66O7 (634.4808)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0)

C38H66O7 (634.4808)


   

DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C38H66O7 (634.4808)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0)

C38H66O7 (634.4808)


   

2-[[(2R)-3-[(E)-hexacos-5-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-[(E)-hexacos-5-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[(2S)-2-decanoyloxy-3-[(E)-hexadec-1-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S)-2-decanoyloxy-3-[(E)-hexadec-1-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[2-decanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-decanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[2-dodecanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-dodecanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[3-[(Z)-hexacos-15-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(Z)-hexacos-15-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[hydroxy-[2-[(Z)-tridec-9-enoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-tridec-9-enoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[2-acetyloxy-3-[(Z)-tetracos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-acetyloxy-3-[(Z)-tetracos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[2-heptanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[hydroxy-[2-tridecanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-tridecanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[2-hexanoyloxy-3-[(Z)-icos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-hexanoyloxy-3-[(Z)-icos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[3-decoxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decoxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[3-[(Z)-henicos-11-enoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(Z)-henicos-11-enoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[3-[(Z)-heptadec-9-enoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(Z)-heptadec-9-enoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[2-butanoyloxy-3-[(Z)-docos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-butanoyloxy-3-[(Z)-docos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[hydroxy-[3-[(Z)-pentadec-9-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(Z)-pentadec-9-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

2-[[3-dodecoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-dodecoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811)


   

(5s)-3-{7-[(2r,5s)-5-[(4s,7r)-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-1,3-dioxepan-4-yl]oxolan-2-yl]heptyl}-5-methyl-5h-furan-2-one

(5s)-3-{7-[(2r,5s)-5-[(4s,7r)-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-1,3-dioxepan-4-yl]oxolan-2-yl]heptyl}-5-methyl-5h-furan-2-one

C38H66O7 (634.4808)


   

2-[(2e,6e,10e,14e,18e,22e)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl]naphthalene-1,4-dione

2-[(2e,6e,10e,14e,18e,22e)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl]naphthalene-1,4-dione

C45H62O2 (634.475)


   

2-[(10e,14e,18e,22e)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl]naphthalene-1,4-dione

2-[(10e,14e,18e,22e)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl]naphthalene-1,4-dione

C45H62O2 (634.475)